Skip to main content
Equibles

MARSHALL WACE, LLP

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1318757 LONDON, X0
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$57,489,474
+$26,106,208 QoQ
Shares Held
704,787
+53.0% QoQ
Ownership
0.844%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#34
of 383 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. PTCT ranks #10 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in PTCT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,489,474 704,787
2026-03-31 $31,383,266 460,638
2025-12-31 $18,818,785 247,746
2025-09-30 $9,680,441 157,739
2025-06-30 $26,264,978 537,776
2025-03-31 $37,761,461 741,002
2024-06-30 $5,494,583 179,679
2024-03-31 $646,350 22,219
2023-06-30 $251,421 6,182
2021-12-31 $240,652 6,042
2021-09-30 $224,822 6,042
2021-06-30 $255,395 6,042
2021-03-31 $2,000,868 42,257
2020-09-30 $1,393,150 29,800
2020-06-30 $1,754,386 34,576